Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeEXECUTIVESJohn Murphy Appointed GTX Medical BV Chief Technology Officer

John Murphy Appointed GTX Medical BV Chief Technology Officer

GTX medical BV today announced the appointment of John Murphy, Ph.D., as Chief Technology Officer (CTO). Dr. Murphy joins the company with over twenty years of experience in Class I, II, and III medical devices and implantables and has been instrumental in bringing numerous new devices to commercialization. As a member of GTX’ leadership team, Dr. Murphy will be responsible for leading and executing the company’s technology strategy and advancing its neuromodulation product portfolio, which is designed to improve the functional recovery of people with spinal cord injuries (SCI). GTX is simultaneously developing both implantable and non-invasive spinal cord stimulation systems to give people with SCI a chance to improve their quality of life.

Commenting on his appointment, Dr. Murphy said, “GTX is a global leader in neuromodulation therapies to treat spinal cord injuries with an innovative and transformative technology that can accelerate recovery and potentially restore locomotion. I believe GTX has the resources in place to significantly improve SCI therapies as well as patient outcomes and I am thrilled to contribute my medtech engineering expertise toward this shared goal.”

“We are very pleased to welcome John to GTX as the company continues to grow and strengthen its management team,” said Jan Öhrström, Chairman of the Board of GTX. “We are thankful for the unified dedication displayed by the GTX team as we continue actively moving forward with our development programs, even during the uncertain times caused by the COVID-19 pandemic. With John joining the team and contributing his technical expertise to our corporate vision, we believe we are in a solid position to continue serving the SCI community in an effort to improve the recovery and quality of life of people with a spinal cord injury.”

Prior to joining GTX, Dr. Murphy was CTO and VP Research and Development at LivaNova, a global medical technology company in Houston, Texas where he contributed to the development of the technology and products as well as generated new therapy roadmaps for their neuromodulation franchise, including implantable pulse generators, programming systems and mobile connectivity solutions. Before LivaNova, he held various leadership roles at St. Jude Medical and was responsible for bringing several products to market including new embedded software for neurostimulators and the first Bluetooth Low Energy implantable medical device on the market. Prior to this, at Medtronic, Dr. Murphy held roles of Systems and Software Manager and Lead Principal R&D Engineer. Dr. Murphy holds a Ph.D. with a focus on analytical design and optimization of ultrasonic vibrational transducers for spinal surgery from the Swiss Federal Institute of Technology of Lausanne (EPFL). He obtained his BS, Electrical Engineering, from the University of North Carolina at Charlotte, USA.

Since the merger with Neurorecovery Technologies, Inc. in October 2019, GTX has grown its operational capabilities in the US with the addition of new clinical, regulatory and management resources which now also includes Dr. Murphy.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy